The Decongestants Market size is estimated to reach $21.3 billion by 2027, growing at an estimated CAGR of 6.3% during the forecast period 2022–2027. Decongestants or nasal decongestants constitute a kind of pharmaceutical medication that is used to alleviate nasal congestion in the upper respiratory tract. North America held the largest Decongestants Market share, with 40% of the overall market in 2021. The effective constituent in nearly all decongestants is either pseudoephedrine or phenylephrine, with questionable efficiency. Numerous independent investigations suggested that it offered no more alleviation to sinus congestion than a placebo. Intranasal corticosteroids can also be used as decongestants, and antihistamines can be used to relieve runny noses, nasal itch, and sneezing. Loss of smell is termed anosmia or impaired smell. Anosmia treatment includes options like decongestants and antihistamines, steroids, and surgery.
Antonio Segovia, MD.
